Press Releases
Progenra Inc. announced continued progress in the development of its small-molecule activators of PINK1 kinase, a key regulator of mitochondrial quality control and cellular energy homeostasis.
Progenra Invited to Speak at Symposium “From Mechanisms to Therapeutic Insight in Neurodegeneration”Progenra Drug Offers Hope for Therapy for Parkinson’s and Alzheimer’s disease
A New Drug Functions in Parkinson’s Disease
Breakthrough Discovery Offers Hope for Precision Therapy in Mitochondrial Dysfunction Disorders
Progenra Invited to Speak at Symposium “From Mechanisms to Therapeutic Insight in Neurodegeneration”Progenra Drug Offers Hope for Therapy for Parkinson’s and Alzheimer’s disease
A New Drug Functions in Parkinson’s Disease
Breakthrough Discovery Offers Hope for Precision Therapy in Mitochondrial Dysfunction Disorders
Let’s Partner for Scientific Breakthroughs
Please contact Progenra Business Development for inquiries: